Faraifarai post on hub: faraifarai Friday, 0

Quote:

---

faraifarai Friday, 05/19/17 09:02:27 AM
Re: Echo20 post# 182554
Post # of 182570

Yep. The writing is on the wall, and not in a bad way. The 10 largest pharmas will likely fight over CTIX's pipeline when results are in. If results continue on the track that has been posted in recent interim results (and topline in 200MG for Prurisol) then you'd have to be living in denial or in fraggle rock to not understand that what Cellceutix has is a world class pipeline. Hey, in the end, I don't care what anyone does on this board or how they invest--i have a large position that I'm holding until what I believe will end up being a massive acquisition, on the low end starting at $3B or roughly $30-40/share. govern yourselves accordingly. Excited for topline results of IBD and OM trials in July, and Prurisol interim also in 3Q17. 10 days until June. June is a psychological milestone. Enter June and you are looking at topline and interims dead in the eye. Tick tock. On the verge--long time coming.

---